Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EVONIK INDUSTRIES AG

(EVK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Evonik Industries : launches ORTEGOL® 700 series of compression set additives to support booming “Bed in a Box” market

09/22/2021 | 09:52am EDT

Essen, Germany. Evonik has introduced its ORTEGOL® 700 series of polyurethane additives to significantly improve the final quality of compressed flexible foams. The new additives enable compressed mattresses to unfold and recover to their original volume much faster. The ORTEGOL® 700 series are also designed to enhance the final performance of compressed foams, especially after long periods of storage and transportation.

"The market for compressed flexible foams has been steadily increasing over recent years. Since the COVID-19 pandemic "Bed in a Box" sales have really boomed as consumers have only been able to buy new mattresses online for delivery in boxes," said Ralph Marquardt, Head of Evonik's polyurethane additives business. "That's why improving the compression properties of polyurethane slabstock foams is more important than ever. To help the industry take advantage of the very high demand, our technical teams have been working hard to develop and quickly bring these game-changing new solutions to market."

Shipments of compressed foams to manufacturers of finished mattresses and foam rolls have also dramatically increased to meet the new demand. However, previously it could take a long time for compressed foams to recover after shipping before being ready for production. In many cases, the foams do not always fully recover, with deformed foams unsuitable for mattress production creating waste. Additionally, today's consumers expect products to be ready straight out of the box. Any foam deformities because of long-term storage in boxes, can often mean mattresses are returned, leading to much higher scrap rates, costly return shipping fees and consumers unlikely to re-purchase.

Evonik has developed and launched its ORTEGOL® 700, ORTEGOL® 701 and ORTEGOL® 702 additives to support the industry overcome these challenges. With significantly improved aging resistance, the new additives have all been optimized for odors and emissions, with each one passing the low VOC Chamber Test. Additionally, ORTEGOL® 701 is also suitable for automotive seating applications and passes the latest VDA 278 standard.

Recommended for use in combination with Evonik's DABCO® NE
range of emission optimized catalysts and TEGOSTAB® surfactants, all three new ORTEGOL® products reduce curing times before compressing, helping to lower costs and significantly improve the compression set during roll tests. In the case of ORTEGOL® 702, foams can be compressed much earlier after curing, usually achieving full recovery after around one day following a long period of compression.

Please watch the video for a simulation of a stored rolled mattresses using the roll test method.

Disclaimer

Evonik Industries AG published this content on 21 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 September 2021 13:51:01 UTC.


© Publicnow 2021
All news about EVONIK INDUSTRIES AG
10/20EVONIK INDUSTRIES : expands production of organic dispersions for heat sealing application..
PU
10/15EVONIK : NorldLB reaffirms its Neutral rating
MD
10/14EVONIK INDUSTRIES : New fumed silica plant by Evonik and Wynca goes on stream in Zhenjiang..
PU
10/14ANALYST RECOMMENDATIONS : Asos, Avis Budget, Meritage Homes, Kansas City Southern, UPS...
10/14EVONIK : Jefferies remains Neutral
MD
10/13EVONIK : UBS remains a Sell rating
MD
10/13EVONIK INDUSTRIES : makes its debut at Tokyo Agri Week
PU
10/11EVONIK : UBS reiterates its Sell rating
MD
10/11EVONIK INDUSTRIES : announces price increase for GuanAMINO®
PU
10/07EVONIK INDUSTRIES : launches novel VESTAMID® polyamide elastomer foam
PU
More news
Analyst Recommendations on EVONIK INDUSTRIES AG
More recommendations
Financials
Sales 2021 13 989 M 16 288 M 16 288 M
Net income 2021 774 M 901 M 901 M
Net Debt 2021 2 624 M 3 055 M 3 055 M
P/E ratio 2021 17,0x
Yield 2021 4,11%
Capitalization 13 104 M 15 242 M 15 257 M
EV / Sales 2021 1,12x
EV / Sales 2022 1,06x
Nbr of Employees 32 661
Free-Float 41,1%
Chart EVONIK INDUSTRIES AG
Duration : Period :
Evonik Industries AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVONIK INDUSTRIES AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 28,12 €
Average target price 31,80 €
Spread / Average Target 13,1%
EPS Revisions
Managers and Directors
Christian Kullmann Chairman-Management Board
Ute Wolf Chief Financial Officer
Bernd Tönjes Chairman-Supervisory Board
Andreas Fischer Chief Innovation Officer
Volker Trautz Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
EVONIK INDUSTRIES AG5.40%15 242
SHIN-ETSU CHEMICAL CO., LTD.6.01%69 840
BASF SE-2.97%67 094
DUPONT DE NEMOURS, INC.1.41%37 718
ROYAL DSM N.V.32.03%36 876
PIDILITE INDUSTRIES LIMITED31.29%15 715